Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules

BACKGROUND: The long-term antibody response to measles vaccine (MV) administered at age 6 months with or without subsequent doses is not well documented. METHODS: Measles serum antibody responses were evaluated after a supplemental dose of measles vaccine (sMV) administered at a median age of 20 mon...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccine
Autors principals: Fowlkes, Ashley L., Witte, Desiree, Beeler, Judy, Audet, Susette A., Broadhead, Robin, Bellini, William J., Cutts, Felicity, Helfand, Rita F.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5737013/
https://ncbi.nlm.nih.gov/pubmed/26873052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.01.055
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars